Jingfeng Medical: Plans to buy back up to 200 million Hong Kong dollars in H shares on the open market.

Jingfeng Medical Announcement: The Board of Directors of the company plans to exercise the general authorization granted by the shareholders at the shareholders' meeting on June 16, 2025, to repurchase H shares up to a maximum of HK$200 million on the open market as deemed appropriate. The repurchase period will end at the next annual shareholders' meeting or when a special resolution is passed to revoke/revise the repurchase authorization.